ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

HIK Hikma Pharmaceuticals Plc

1,953.00
18.00 (0.93%)
20 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Hikma Pharmaceuticals Plc LSE:HIK London Ordinary Share GB00B0LCW083 ORD SHS 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  18.00 0.93% 1,953.00 1,951.00 1,952.00 1,959.00 1,919.00 1,932.00 801,595 16:35:05
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 2.88B 192M 0.8653 22.56 4.29B
Hikma Pharmaceuticals Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker HIK. The last closing price for Hikma Pharmaceuticals was 1,935p. Over the last year, Hikma Pharmaceuticals shares have traded in a share price range of 1,750.00p to 2,165.00p.

Hikma Pharmaceuticals currently has 221,886,453 shares in issue. The market capitalisation of Hikma Pharmaceuticals is £4.29 billion. Hikma Pharmaceuticals has a price to earnings ratio (PE ratio) of 22.56.

Hikma Pharmaceuticals Share Discussion Threads

Showing 926 to 949 of 1875 messages
Chat Pages: Latest  39  38  37  36  35  34  33  32  31  30  29  28  Older
DateSubjectAuthorDiscuss
14/3/2018
07:41
What will happen today after these results ?
gerrym two
12/3/2018
16:42
Certainly could have been worse today - the drop was no worse than daily noise of the last few weeks.

Hopefully they can come up with a decent set of results, and paint a rosy picture going forward

nav_mike
12/3/2018
09:33
Share price reaction could have been worse.

No point in selling at the bottom, if indeed it should prove so.

broadwood
12/3/2018
08:37
2 year delay
r ball
12/3/2018
08:31
This is old news. Just new detail.

At least now we know where we are with the FDA. New trial will/should produce the expected results. Bit disappointed it's going to take so long though.

As said above, fingers crossed for a decent set of results.

bantam175
12/3/2018
08:07
Oh well at least if the results are half-decent on Wednesday they wont get tarnished by the news we've had today - markets will have digested the implications by then
nav_mike
12/3/2018
08:04
That bid story:

Copycat drug makers on alert as Germany's Stada eyes acquisition spree


"Mr Albrecht was tight-lipped on a UK target but City analysts suggested that beleaguered London-listed firms Vectura and Hikma could fit the bill – two companies developing generic drugs, products with expired patents."

kamitora
12/3/2018
07:52
A bid would suit me.
Suet

suetballs
12/3/2018
07:49
Bad news, heading South I fear.

How much is in the price? It has had a spectacular fall.

broadwood
12/3/2018
07:34
Jeez...perfect timing to nullify the potential bid story in the Telegraph at the weekend

Ho hum

nav_mike
12/3/2018
07:24
For sure that will the share price but I think it will recover quickly
sandeep67
12/3/2018
07:20
Original FDA decision upheld. Hikma to do further work with Advair possibly by early 2019.
sza2002
01/3/2018
19:07
The market ignoring Barclays on HIK - Sweet! - Do these brokers make it up as they go along? (It's a bit like listening to the Horse Racing punters!)

Is there really any credibility in what they have to say? If so, why are there so many varying opinions from different brokers? Would they not all agree on a company's fundamentals and trading position and paint a similar outlook? Been trading over 25 years, I'm still not smart enough to work this one out!! :-/

HIK were tipped several times over Christmas & New Year. Is this a broker looking for discounted prices and wishing to grab a bargain? Then ramp it up from a Sell, to a Hold, to a Buy?.. ...They're all in pole position to do this after all!

nickg100
01/3/2018
16:58
Flippin eck what happened here today?

Went out this morning with price at 825 after the Barclays downgrade, and come back to 871 and blue on the day...

Im sure there were people trading with knowledge of the downgrade yesterday....the BOTs were absolutely relentless all day - or maybe im just too cynical...nah!

nav_mike
01/3/2018
09:13
I bought in here at £20 last year thinking I got a good price ? keep the faith people I'm still hopeful
gozzy90
01/3/2018
08:31
I feel ur pain bro , my avg now about a tenner , ho hum.
death by donut
01/3/2018
08:23
Remind me to thank Barclays after I topped up yesterday - another inspired purchase :)
nav_mike
01/3/2018
08:09
Barclays downgrades to 800p target from 1500.

What they gonna say after results?

bantam175
27/2/2018
17:28
Fingers crossed then; anything along those lines would be welcome.
fhmktg
27/2/2018
15:56
We should get an update on 14th March. Last RNS said, the issue with FDA taken to complaint resolution committee, expected to deliberate in Q1. I guess the best we expect is an agreement on what needs to be done to get FDA approval.
karateboy
26/2/2018
12:16
Any thoughts on the timing of news on the Advair issue?
fhmktg
22/2/2018
15:41
Aaaaaaaand down . DbD :-(
death by donut
20/2/2018
16:36
This may stop recent share price drops until results in March. It is always a good news to separate chairman and CEO roles from each other.
karateboy
20/2/2018
12:24
The markets agree with you R Ball - I didn't see this coming!

Over 100p thus far today. Great news from HIK :-D

nickg100
Chat Pages: Latest  39  38  37  36  35  34  33  32  31  30  29  28  Older

Your Recent History